RxDoctor Payments Data

Andrew Nye, DO

Family Medicine · Oviedo, FLNPI 1639365893

Payments from drug & device makers

$1,060in general payments, 2019–2025

Across 77 payments — averaging $13.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$200
  • Novo Nordisk$174
  • Exact Sciences$157
  • AstraZeneca$140
  • Sanofi-aventis U.S. LLC$108
  • Lilly USA, LLC$91
  • plus $191 from 8 others

What the payments were for

  • Food & beverage$1,03998%
  • Education$212%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,060 in reported general payments places this provider in the 65th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$67,348
Medicare patients
189
Services billed
686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin56$71,703
MounjaroTirzepatide47$54,802
OzempicSemaglutide36$51,255
MyrbetriqMirabegron16$10,871
SynthroidLevothyroxine Sodium37$3,023
Duloxetine Hcl131$2,415
Rosuvastatin Calcium173$1,682
Lisinopril226$1,391
Levothyroxine Sodium197$1,347
Fenofibrate40$1,332
Famotidine78$1,245
Tamsulosin Hcl59$1,090
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine14$1,057
Ezetimibe30$1,049
Omeprazole83$1,029

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$200$71,70356 claims
Lilly USA, LLCMounjaro$91$54,80247 claims
Novo NordiskOzempic$174$51,25536 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Oviedo

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →